Share on StockTwits

OHR Pharmaceutical (NASDAQ:OHRP) Director Ira A. Greenstein purchased 1,000 shares of the stock on the open market in a transaction that occurred on Wednesday, July 2nd. The stock was purchased at an average price of $8.40 per share, with a total value of $8,400.00. Following the completion of the transaction, the director now directly owns 456,496 shares in the company, valued at approximately $3,834,566. The transaction was disclosed in a filing with the SEC, which is available at this link.

Shares of OHR Pharmaceutical (NASDAQ:OHRP) opened at 8.12 on Monday. OHR Pharmaceutical has a one year low of $5.65 and a one year high of $20.00. The stock’s 50-day moving average is $8.83 and its 200-day moving average is $10.93. The company’s market cap is $191.8 million.

Separately, analysts at Brean Capital raised their price target on shares of OHR Pharmaceutical from $21.00 to $34.00 in a research note on Tuesday, June 24th. They now have a “buy” rating on the stock.

Ohr Pharmaceutical Inc (NASDAQ:OHRP) is a biotechnology rollup company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.